Amylyx Pharmaceuticals Inc. has won its first approval from the U.S. Food and Drug Administration for a drug designed to treat amyotrophic lateral sclerosis, or ALS. Click here to view original post
The East Bay public health system is sounding the alarm as incidents of gunshot wounds continue to rise. OAKLAND, Calif., Sept. 29, 2022 /PRNewswire/ — Alameda Health System’s Highland Hospital received three victims of the […]
When glacial ice sheets melt, something counterintuitive happens to sea levels. Logic might suggest that nearby levels would rise, but instead they fall. Thousands of miles away, however, they do go up in a kind […]
New sequencing technologies and capabilities will accelerate the genomic discoveries and clinical insights needed to transform human health Revolutionary NovaSeq X Series sets new benchmark for speed, scale, accuracy, and sustainability SAN DIEGO, Sept. 29, […]
The FDA approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. Click here to view original post Click here to view original post
The school will be renamed after one of the university’s former presidents and an alumnus who was an accomplished clarinetist — both of whom grew up together in Rhode Island. Click here to view original […]
NEWARK, Del., Sept. 29, 2022 /PRNewswire/ — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces a Biomanufacturing Readiness Levels (BRLs) framework to lay the groundwork for a universal assessment of technology maturity and […]
LOWELL, Mass. & WESTON, Fla.–(BUSINESS WIRE)–Dave Shaw, senior managing director and global HR transformation/delivery lead at Accenture, has joined The Workforce Institute at UKG advisory board. Click here to view original post
ALEXANDRIA, Va.–(BUSINESS WIRE)–A new survey by the Prevent Cancer Foundation® reveals an alarming statistic: almost half (49%) of American women 40 and older report they have not had a breast cancer screening in more than […]
Payton Dupuis’s interest in biology research began where it does for many future scientists — witnessing a relative struggling with an incurable medical condition. For Dupuis, that family member was her uncle, who suffered from […]
© 2023 Biotech Networks, LLC
